[Federal Register Volume 77, Number 240 (Thursday, December 13, 2012)]
[Notices]
[Page 74197]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2012-30024]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2012-N-0001]


Neurological Devices Panel of the Medical Devices Advisory 
Committee; Notice of Meeting; Correction

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice; correction.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is correcting a notice 
that appeared in the Federal Register of Friday, December 7, 2012 (77 
FR 73034). The product name in the document was incorrect. This 
document corrects that error.

FOR FURTHER INFORMATION CONTACT: Natasha Facey, Center for Devices and 
Radiological Health, Food and Drug Administration, 10903 New Hampshire 
Ave., Silver Spring, MD 20993, 301-796-5290, [email protected].

SUPPLEMENTARY INFORMATION: In FR doc. 2012-29538, appearing on page 
73034 in the Federal Register of Friday, December 7, 2012, the 
following correction is made:
    1. On page 73034, in the second column under the section entitled 
``Agenda'', the product name ``NeuroPace Responsive Neurostimulation 
(RNS) System'' is corrected to read ``NeuroPace RNS System''.

    Dated: December 7, 2012.
Jill Hartzler Warner,
Acting Associate Commissioner for Special Medical Programs.
[FR Doc. 2012-30024 Filed 12-12-12; 8:45 am]
BILLING CODE 4160-01-P